Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity (Q36959145)
Jump to navigation
Jump to search
scientific article published on 04 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity |
scientific article published on 04 June 2013 |
Statements
1 reference
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity (English)
1 reference
1 reference
A Loganayagam
1 reference
M Arenas Hernandez
1 reference
A Corrigan
1 reference
L Fairbanks
1 reference
P Harper
1 reference
N Maisey
1 reference
P Ross
1 reference
J D Sanderson
1 reference
A M Marinaki
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference